Khoury JD, Solary E, Abla O, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and Histiocytic/Dendritic neoplasms. Leukemia. 2022;36:1703–19.

Article  PubMed  PubMed Central  Google Scholar 

Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol. 2024;99:1142–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marando L, Csizmar CM, Patnaik MM. Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica. 2025;110:22–36.

CAS  PubMed  Google Scholar 

Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18:437–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wright CJ, Smith CWJ, Jiggins CD. Alternative splicing as a source of phenotypic diversity. Nat Rev Genet. 2022;23:697–710.

Article  CAS  PubMed  Google Scholar 

Bradley RK, Anczuków O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choquet K, Patop IL, Churchman LS. (2025) The regulation and function of post-transcriptional RNA splicing. Nat Rev Genet 1–17.

Wilkinson ME, Charenton C, Nagai K. RNA splicing by the spliceosome. Annu Rev Biochem. 2020;89:359–88.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.

Article  CAS  PubMed  Google Scholar 

Adema V, Hirsch CM, Przychodzen BP, et al. Somatic PRPF8 mutations in myeloid neoplasia. Blood. 2017;130:584.

Google Scholar 

Saez B, Walter MJ, Graubert TA. Splicing factor gene mutations in hematologic malignancies. Blood. 2017;129:1260–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Benbarche S, Abdel-Wahab O. Splicing factor mutations in hematologic malignancies. Blood. 2021;138:599–612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor J, Mi X, North K, et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 2020;136:1477–86.

Article  PubMed  PubMed Central  Google Scholar 

Pangallo J, Kiladjian J-J, Cassinat B, Renneville A, Taylor J, Polaski JT, North K, Abdel-Wahab O, Bradley RK. Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood. 2020;135:1032–43.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, Raza A, Mukherjee S, Manley JL. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc Natl Acad Sci. 2015;112:E4726–34.

CAS  PubMed  PubMed Central  Google Scholar 

Kim E, Ilagan JO, Liang Y, et al. SRSF2 mutations contribute to myelodysplasia through Mutant-Specific effects on exon recognition. Cancer Cell. 2015;27:617–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Darman RB, Seiler M, Agrawal AA, et al. Cancer-Associated SF3B1 hotspot mutations induce cryptic 3′ splice site selection through use of a different branch point. Cell Rep. 2015;13:1033–45.

Article  CAS  PubMed  Google Scholar 

Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 2015;25:14–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okeyo-Owuor T, White BS, Chatrikhi R, et al. U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing. Leukemia. 2015;29:909–17.

Article  CAS  PubMed  Google Scholar 

Ferrer A, Lasho T, Fernandez JA, et al. Patients with telomere biology disorders show context specific somatic mosaic States with high frequency of U2AF1 variants. Am J Hematol. 2023. https://doi.org/10.1002/ajh.27086.

Article  PubMed  Google Scholar 

Badar T, Vanegas YAM, Nanaa A, et al. U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood Cancer J. 2023;13:1–7.

Article  Google Scholar 

Shen H, Zheng X, Luecke S, Green MR. The U2AF35-related protein urp contacts the 3’ splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev. 2010;24:2389–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madan V, Kanojia D, Li J, et al. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun. 2015;6:6042.

Article  CAS  PubMed  Google Scholar 

Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis. Blood. 2023;142:2235–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangaonkar AA, Patnaik MM. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations. Am J Hematol. https://doi.org/10.1002/ajh.26915

Pritzl SL, Gurney M, Badar T, et al. Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective Mayo clinic cohort study. Leuk Res. 2023;125:107007.

Article  CAS  PubMed  Google Scholar 

Abelson S, Collord G, Ng SWK, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018;559:400–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabre MA, de Almeida JG, Fiorillo E, et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature. 2022;606:335–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Z, Campestri G, Lasho T, et al. Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML. Leuk Res. 2022;116:106818.

Article  CAS  PubMed  Google Scholar 

Kon A, Yamazaki S, Nannya Y, et al. Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice. Blood. 2018;131:621–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coltro G, Mangaonkar AA, Lasho TL, et al. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients. Leukemia. 2020;34:1407–21.

Article  CAS  PubMed  Google Scholar 

Palomo L, Meggendorfer M, Hutter S, et al. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. Blood. 2020;136:1851–62.

Article  PubMed  PubMed Central  Google Scholar 

Itzykson R, Kosmider O, Renneville A, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013;121:2186–98.